Stock info Arrowhead Research | Filter  Basic-Info

Stock: Arrowhead Research (US broad)

Last Price 30.69 Max Price 30.69
Min Price 9.99 1 Year return 63.24
Sector Health Care Subsector Biotechnology

Loading...

Contact info:Street: 225 South Lake Avenue,Suite 1050Zip Code: CA 91101City: PasadenaCountry: USAPhone: 626-304-3400Email: ir@arrowres.comWebsite: www.arroweadresearc.comCEO: Dr. Christopher R. Anzalone Ph.D.CFO: Mr. Kenneth A. Myszkowski CPA

Sector Review Arrowhead Research

Loading...
Year Turnover Total sector Market share
2019 155 136,070 0.11 %
2020 75 153,065 0.05 %
2021 119 227,669 0.05 %
2022 248 260,393 0.10 %
2023 228 215,054 0.11 %

Advice Arrowhead Research

No Records Found




News Arrowhead Research

No Records Found

Annual reports Arrowhead Research

No Records Found


Profile Arrowhead Research

Arrowhead Research


The past year was a good year for Arrowhead Research investors

The period between December 2015 and December 2016 was a loss-making period for the investors in Arrowhead Research. The stock lost around 79 percent. Over the past 5 years the stock lost a massive -69,71 percent. Arrowhead Research's revenues between 2011 and 2015 were very volatile and moved between 0,15 million dollars and 0,38 million dollars. Arrowhead Research's net incomes between 2011 and 2015 were very volatile and moved between -8,79 million dollars and -91,94 million dollars.

Arrowhead Research's head office is located in Pasadena. The core activities of Arrowhead Research are in the health care eq. & services sector. Dr. Christopher R. Anzalone Ph.D. is leading the company as CEO. Arrowhead Research' CFO is Mr. Kenneth A. Myszkowski CPA. The period from 2006 till the end of 2016 the international sector gained around 102 percent. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-2016) there is a plus of 102 percent.

Arrowhead Research didn't pay out any dividends (in the past 5 years).

Arrowhead Research financed with relatively a lot of debt

At the end of 2015 the American company had a balance sheet of around 132,27 million dollars. At the end of 2015 the total debt positon equaled 22,09 million dollars. This is around 16,7 percent of the total balance sheet. The American company's price/earnings-ratio was -5. So the market valued the stock at -5 times the 2015' earnings per share. Based on the classical stock valuation theories the American stock can be seen as a value stock.

At the end of 2015 the market capitalization (the number of shares outstanding multiplied by the stock price) of the health care company equaled around 343,58 million dollars. At the end of 2015 the American company had around 57,36 million stocks listed on the stock exchange(s).

All Arrowhead Research's annual reports can be found here. More information about Arrowhead Research can be found it's website. .


Results Arrowhead Research

Results
2021
2022
2023
2024
2025
Revenue
Costs
Profit
Margin of profit
ROI

Balance Arrowhead Research

Balance
2021
2022
2023
2024
2025
Equity
Debt
Total assets
Solvency
Cash
Cashflow
Employees
Revenue per employee
Cashflow / Debt

Details Arrowhead Research

Details
2016
2017
2018
2019
2020
Price
1.55
3.68
12.42
63.43
76.73
Eps
-1.19
-0.39
-0.56
0.63
-0.72
Price/earnings-ratio
-1.30
-9.44
-22.18
100.68
-42.62
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
1.22
0.92
0.93
2.35
3.85
Market to book
0.79
0.25
0.08
0.04
0.13
Cashflow per stock
-0.82
-0.27
-0.46
1.66
-0.80
Stocks
70
75
89
96
102
Market Cap
108.11
275.21
1.099.24
6.057.96
3.141.92

Dividend Arrowhead Research


Price info Arrowhead Research

Date
Price
22 Sep 2025
30.69
16 Sep 2025
28.67
08 Sep 2025
27.17
01 Sep 2025
22.03
21 Aug 2025
20.20
15 Aug 2025
18.78
07 Aug 2025
16.06
23 Jul 2025
14.96
18 Jul 2025
16.76
17 Jul 2025
18.85
16 Jul 2025
18.30
15 Jul 2025
17.63
14 Jul 2025
18.61
11 Jul 2025
18.31
10 Jul 2025
18.86
09 Jul 2025
18.88
08 Jul 2025
17.54
07 Jul 2025
16.84
03 Jul 2025
16.79
02 Jul 2025
16.90
01 Jul 2025
16.09
30 Jun 2025
15.80
27 Jun 2025
16.08
26 Jun 2025
16.07
25 Jun 2025
15.66
24 Jun 2025
15.96
23 Jun 2025
15.51
20 Jun 2025
15.32
18 Jun 2025
15.62
17 Jun 2025
15.50